JPMorgan Chase & Co. cut its holdings in Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 44.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,802 shares of the company’s stock after selling 34,750 shares during the quarter. JPMorgan Chase & Co.’s holdings in Addus HomeCare were worth $5,168,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of ADUS. Larson Financial Group LLC lifted its position in Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after acquiring an additional 136 shares during the period. AlphaQuest LLC purchased a new stake in Addus HomeCare in the third quarter worth about $37,000. Wexford Capital LP purchased a new stake in Addus HomeCare in the third quarter worth about $41,000. State of Wyoming bought a new position in shares of Addus HomeCare during the second quarter valued at approximately $47,000. Finally, Raymond James Financial Inc. bought a new position in shares of Addus HomeCare during the second quarter valued at approximately $61,000. 95.35% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other Addus HomeCare news, EVP Brian Poff sold 2,041 shares of Addus HomeCare stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total value of $218,346.18. Following the completion of the sale, the executive vice president owned 64,512 shares of the company’s stock, valued at approximately $6,901,493.76. This trade represents a 3.07% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R Dirk Allison sold 4,988 shares of the business’s stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total value of $533,616.24. Following the completion of the transaction, the chief executive officer owned 185,514 shares of the company’s stock, valued at $19,846,287.72. This represents a 2.62% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 16,610 shares of company stock worth $1,768,970 in the last three months. Corporate insiders own 4.50% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on ADUS
Addus HomeCare Trading Up 0.2%
NASDAQ:ADUS opened at $93.85 on Thursday. The stock has a market cap of $1.75 billion, a price-to-earnings ratio of 18.01, a PEG ratio of 1.30 and a beta of 0.92. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.11. The company’s 50 day moving average price is $104.87 and its 200-day moving average price is $110.71. Addus HomeCare Corporation has a 52 week low of $92.82 and a 52 week high of $124.43.
Addus HomeCare Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Recommended Stories
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
